Martin Babler's Net Worth
$1.08 Million
Who is Martin Babler?
Martin Babler has an estimated net worth of $1.08 Million. This is based on reported shares across multiple companies, which include ZS Pharma, Inc., Prelude Therapeutics Inc, Omega Alpha SPAC, Neoleukin Therapeutics, Inc., Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., 89bio, Inc., and ALUMIS INC..
SEC CIK
Martin Babler's CIK is 0001435618
Past Insider Trading and Trends
2024 was Martin Babler's most active year for acquiring shares with 12 total transactions. Martin Babler's most active month to acquire stocks was the month of May. 2020 was Martin Babler's most active year for disposing of shares, totalling 15 transactions. Martin Babler's most active month to dispose stocks was the month of August. 2015 saw Martin Babler paying a total of $222,280.00 for 5,000 shares, this is the most they've acquired in one year. In 2020 Martin Babler cashed out on 1,080,074 shares for a total of $1,030,188.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZS Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.00K |
$90.00 | -$90,000.00 |
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Alpha SPAC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neoleukin Therapeutics, Inc. (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
President, CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -58.56K |
$100.00 | -$5,855,700.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
$32.43 | -$882,923.07 | 810 |
Scheduled
|
Jun 23
| ||
Form 4
| -20.68% | -15.00K |
$63.47 | -$952,083.08 | 57.53K |
Scheduled
|
Feb 10 - Mar 5
| ||
Form 4
| -29.69% | -29.50K |
$53.31 | -$1,565,454.84 | 69.88K |
Scheduled
|
Dec 17 - Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +22.31% | 3.68K |
—
|
—
| 20.2K |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||